HIV-1 pol replication capacity predicts disease progression

被引:26
作者
Daar, ES
Kesler, KL
Wrin, T
Petropoulo, CJ
Bates, M
Lail, A
Hellmann, NS
Gomperts, E
Donfield, S
机构
[1] Univ Calif Los Angeles, Harbor Med Ctr, Los Angeles BioMed Res Inst, Div HIV Med, Torrance, CA 90502 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Torrance, CA 90509 USA
[3] Rho Inc, Chapel Hill, NC USA
[4] ViroLogic Inc, San Francisco, CA USA
[5] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
关键词
HIV; pathogenesis; replication capacity; fitness;
D O I
10.1097/01.aids.0000171400.15619.e1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To determine the influence of pol replication capacity on the natura I history of HIV-1 infection. Design: Pol replication capacity was measured using a recombinant virus single cycle assay on baseline plasma specimens from subjects enrolled in the Hemophilia Growth and Development Study. Setting: Children and adolescents with hemophilia and HIV-1 infection were enrolled at multiple sites across the USA into a natural history study. Participants: The Hemophilia Growth and Development Study enrolled 207 HIV-1-infected hemophiliacs between 6 and 19 years of age in 1989 and 1990. Subjects were followed every 6 months through 1997 with pol replication capacity measurements available from 128 of the subjects. Main outcome measures: A univariate model defined the relationship between pol replication capacity and HIV-1 RNA and CD4 T-cell number. A random effects model assessed the ability of this measure to predict CD4 T-cell decline over time and a Cox proportional hazards model and Kaplan-Meier analyses defined how it predicts clinical progression. Results: Pol replication capacity measures correlated with baseline HIV-1 RNA, R-2 = 0.189 (P = 0.03) and CD4 T-cell number, -0.197 (P = 0.03). It also independently predicted CD4 T-cell decline over time and progression to AIDS. Conclusions: This study demonstrates that pol replication capacity independently influences the natural history of HIV-1 infection. (c) 2005 Lippincott Williams & Wilkins.
引用
收藏
页码:871 / 877
页数:7
相关论文
共 30 条
[1]   Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection [J].
Barbour, JD ;
Hecht, FM ;
Wrin, T ;
Segal, MR ;
Ramstead, CA ;
Liegler, TJ ;
Busch, MP ;
Petropoulos, CJ ;
Hellmann, NS ;
Kahn, JO ;
Grant, RM .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (02) :251-256
[2]   Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma [J].
Campbell, TB ;
Schneider, K ;
Wrin, T ;
Petropoulos, CJ ;
Connick, E .
JOURNAL OF VIROLOGY, 2003, 77 (22) :12105-12112
[3]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[4]  
Centers for Disease Control (CDC), 1987, MMWR Suppl, V36, p1S
[5]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628
[6]   INCREASED VIRAL BURDEN AND CYTOPATHICITY CORRELATE TEMPORALLY WITH CD4+ T-LYMPHOCYTE DECLINE AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS [J].
CONNOR, RI ;
MOHRI, H ;
CAO, YZ ;
HO, DD .
JOURNAL OF VIROLOGY, 1993, 67 (04) :1772-1777
[7]  
DAAR E, 2003, 43 INT C ANT AG CHEM
[8]   SEQUENTIAL DETERMINATION OF VIRAL LOAD AND PHENOTYPE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
CHERNYAVSKIY, T ;
ZHAO, JQ ;
KROGSTAD, P ;
CHEN, ISY ;
ZACK, JA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (01) :3-9
[9]   Effects of plasma HIV RNA, CD4+ T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs [J].
Daar, ES ;
Lynn, H ;
Donfield, S ;
Gomperts, E ;
Hilgartner, MW ;
Hoots, K ;
Chernoff, D ;
Winkler, C ;
O'Brien, SJ .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (04) :317-325
[10]   Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. [J].
Deeks, SG ;
Wrin, T ;
Liegler, T ;
Hoh, R ;
Hayden, M ;
Barbour, JD ;
Hellmann, NS ;
Petropoulos, CJ ;
McCune, JM ;
Hellerstein, MK ;
Grant, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :472-480